Wyeth/Amgen Enbrel Adds 25,000 Patients In Q1; Prevnar Back Orders Cleared
Executive Summary
Improved supply for Wyeth/Amgen's Enbrel is allowing for the first significant increase in the number of patients on the TNF inhibitor in more than a year
You may also be interested in...
Wyeth Allocates Prempro/Premarin Inventories; Stocking Too High, Firm Says
Wyeth has implemented temporary allocation caps on its conjugated estrogens product line in an effort to reduce inventories in the trade
Wyeth Allocates Prempro/Premarin Inventories; Stocking Too High, Firm Says
Wyeth has implemented temporary allocation caps on its conjugated estrogens product line in an effort to reduce inventories in the trade
Wyeth Prempro Gets Dementia Warning; FDA Considering HRT Class Labeling
FDA is considering hormone replacement therapy class labeling that would incorporate data from a WHI sub-study showing twice the rate of dementia in patients taking Wyeth's Prempro estrogen/progestin combo